Accuvest Global Advisors’s Gilead Sciences GILD Stock Holding History

Accuvest Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,852	Closed	-$556K	–	97
2017 Q2	$556K	Sell	7,852 -8,286	-51%	-$551K	0.18%	53
2017 Q1	$1.1M	Buy	16,138 +11,727	+266%	+$825K	0.35%	33
2016 Q4	$316K	Sell	4,411 -4,833	-52%	-$359K	0.29%	41
2016 Q3	$731K	Buy	9,244 +4,902	+113%	+$398K	0.2%	44
2016 Q2	$362K	Sell	4,342 -2,200	-34%	-$195K	0.22%	48
2016 Q1	$601K	Hold	6,542	–	–	0.29%	38
2015 Q4	$662K	Hold	6,542	–	–	0.29%	39
2015 Q3	$642K	Hold	6,542	–	–	0.29%	36
2015 Q2	$766K	Hold	6,542	–	–	0.29%	40
2015 Q1	$642K	Sell	6,542 -6,542	-50%	-$664K	0.25%	40
2014 Q4	$1.23M	Buy	+13,084	New	+$1.35M	0.26%	49
2014 Q3	–	Sell	-8,300	Closed	-$688K	–	76
2014 Q2	$688K	Buy	+8,300	New	+$646K	0.21%	47

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Accuvest Global Advisors's GILD Position: Q3 2017 in Review

Accuvest Global Advisors sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 7,852 shares — an estimated $556K sold.

Accuvest Global Advisors first reported a position in GILD in Q2 2014 and held it in 12 quarters. The position peaked at $1.23M in Q4 2014. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

Accuvest Global Advisors reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
Accuvest Global Advisors sold 7,852 Gilead Sciences shares in Q3 2017, an estimated $556K.
Accuvest Global Advisors first reported a position in Gilead Sciences in Q2 2014 and held it in 12 quarters.
Accuvest Global Advisors's Gilead Sciences position peaked at $1.23M in Q4 2014.
1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Accuvest Global Advisors's 13F filing for Q3 2017, filed 8 Nov 2017.